Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase InhibitorAntonia F. Stepan, Christopher J. O’Donnell, Yasong Lu et al.|Journal of Medicinal Chemistry|2012Cited by 460
Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase InhibitorsAntonia F. Stepan, R. Scott Obach, Kapil Karki et al.|Journal of Medicinal Chemistry|2011Cited by 106
Quantitative Pharmacokinetic/Pharmacodynamic Analyses Suggest That the 129/SVE Mouse Is a Suitable Preclinical Pharmacology Model for Identifying Small-Molecule γ-Secretase InhibitorsYasong Lu, David Riddell, Liming Zhang et al.|Journal of Pharmacology and Experimental Therapeutics|2011Cited by 24
CCDC 858020: Experimental Crystal Structure DeterminationAntonia F. Stepan, Christopher J. O’Donnell, Chakrapani Subramanyam et al.|The Cambridge Structural Database|2013Cited by 0
P4–278: Clinical gamma‐secretase inhibitors (GSIs) alter beta‐amyloid 40/42 ratio in brain and show CSF beta‐amyloid rebound <i>in vivo</i>Charles E. Nolan, David Riddell, Kevin Atchison et al.|Alzheimer s & Dementia|2013Cited by 0